|
Volumn 9, Issue 2, 2000, Pages 67-70
|
Management of peritoneal and hepatic metastases from gastrointestinal stromal tumors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DACTINOMYCIN;
DOXORUBICIN;
GEMCITABINE;
IFOSFAMIDE;
MITOMYCIN;
MITOXANTRONE;
NEW DRUG;
RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
VINBLASTINE;
VINCRISTINE;
ARTICLE;
ARTIFICIAL EMBOLISM;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GRADING;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG RESPONSE;
GASTROINTESTINAL TUMOR;
HEPATIC ARTERY;
HUMAN;
LEIOMYOSARCOMA;
LIVER METASTASIS;
PERITONEUM METASTASIS;
PRIORITY JOURNAL;
STROMA CELL;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
FEMALE;
GASTROINTESTINAL NEOPLASMS;
HUMANS;
LIVER NEOPLASMS;
MALE;
PERITONEAL NEOPLASMS;
PROGNOSIS;
SARCOMA;
SURVIVAL RATE;
|
EID: 0033677771
PISSN: 09607404
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-7404(00)00027-X Document Type: Article |
Times cited : (23)
|
References (21)
|